ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, United Therapeutics Corporation (UTHR) shows an Average True Range (ATR) of 14.29 and an Enterprise Value of 10.65B. Its average trading volume over the past 3 months is 724.5K, indicating liquidity. These fundamental metrics provide insight into UTHR's underlying financial health and market activity.
United Therapeutics Corporation (UTHR) technical indicators as of October 2, 2025: the SMA 20 is 6.75%, SMA 50 at 25.49%, and SMA 200 at 34.69%. The RSI 14 value is 69.23, suggesting its current momentum. These technical analysis signals help assess UTHR's price trends and potential future movements.
United Therapeutics Corporation (UTHR) stock performance overview as of October 2, 2025: The 52-week high is $444.57 (currently 0.32% below), and the 52-week low is $266.98 (currently 66.09% above). Over the past year, UTHR's performance is 23.68%, compared to the S&P 500's 15.68% change.
According to market data, United Therapeutics Corporation (UTHR) stock's recent performance metrics show that over the last month, UTHR is 13.28%, with a Year-to-Date (YTD) performance of 25.68%. Over the past year, the stock has seen a 23.68% change. These figures summarize UTHR's price movements across various periods, reflecting its historical returns.
According to current financial data, UTHR stock's P/E (TTM) ratio is 16.08, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for UTHR, including P/S (6.51), P/B (2.78), and P/FCF (18.70), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.